WPD Pharmaceuticals Inc
WPD Pharmaceuticals Inc. does not have any significant operations. Previously, it was engaged in the research and development of medicinal products in the fields of oncology. The company is headquartered in Vancouver, Canada.
WPD Pharmaceuticals Inc (WPDPF) - Total Liabilities
Latest total liabilities as of September 2024: $914.82K USD
Based on the latest financial reports, WPD Pharmaceuticals Inc (WPDPF) has total liabilities worth $914.82K USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
WPD Pharmaceuticals Inc - Total Liabilities Trend (2006–2023)
This chart illustrates how WPD Pharmaceuticals Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
WPD Pharmaceuticals Inc Competitors by Total Liabilities
The table below lists competitors of WPD Pharmaceuticals Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Graycliff Exploration Limited
PINK:GRYCF
|
USA | $479.02K |
|
Tedea Technological Development and Automation Ltd
TA:TEDE
|
Israel | ILA5.25 Million |
|
Ather Energy Limited
NSE:ATHERENERG
|
India | ₹17.22 Billion |
|
Barr (A G) PLC
STU:AF72
|
Germany | €109.00 Million |
|
KEPPEL (KEP1.SG)
STU:KEP1
|
Germany | €15.82 Billion |
|
HARMONIC (HMC.SG)
STU:HMC
|
Germany | €330.92 Million |
Liability Composition Analysis (2006–2023)
This chart breaks down WPD Pharmaceuticals Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how WPD Pharmaceuticals Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for WPD Pharmaceuticals Inc (2006–2023)
The table below shows the annual total liabilities of WPD Pharmaceuticals Inc from 2006 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $902.37K | +62.69% |
| 2022-12-31 | $554.64K | -90.63% |
| 2021-12-31 | $5.92 Million | +275.53% |
| 2020-12-31 | $1.58 Million | +82.42% |
| 2019-12-31 | $864.48K | -70.77% |
| 2018-12-31 | $2.96 Million | +2952.05% |
| 2017-12-31 | $96.91K | -63.10% |
| 2016-12-31 | $262.64K | +355.15% |
| 2015-12-31 | $57.70K | +67.19% |
| 2014-12-31 | $34.51K | +431.05% |
| 2013-12-31 | $6.50K | -53.45% |
| 2012-12-31 | $13.96K | +9.65% |
| 2011-12-31 | $12.73K | -7.22% |
| 2010-12-31 | $13.72K | -64.04% |
| 2009-12-31 | $38.16K | +277.12% |
| 2008-12-31 | $10.12K | -5.47% |
| 2007-12-31 | $10.70K | +791.26% |
| 2006-12-31 | $1.20K | -- |